Skip to main navigation Skip to search Skip to main content

Sodium dodecyl sulphate-supported nanocomposite as drug carrier system for controlled delivery of ondansetron

  • Gaurav Sharma*
  • , Mu Naushad
  • , Bharti Thakur
  • , Amit Kumar
  • , Poonam Negi
  • , Reena Saini
  • , Anterpreet Chahal
  • , Ashok Kumar
  • , Florian J. Stadler
  • , U. M.H. Aqil
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

Sodium dodecyl sulphate-supported iron silicophosphate (SDS/FeSP) nanocomposite was successfully fabricated by the co-precipitation method. The SDS/FeSP nanocomposite was investigated as a drug carrier for ondansetron. The cumulative drug release of ondansetron was observed at various pH values for different time intervals, i.e., from 20 min to 48 h. A ranking of the drug release was observed at different pHs; pH 2.2 > saline (pH 5.5) > pH 7.4 > pH 9.4 > distilled water. Maximum release of encapsulated drug was found to be about 45.38% at pH 2.2. The cell viability tests of SDS/FeSP nanocomposite concluded that SDS/FeSP nanocomposite was non-cytotoxic in nature.

Original languageEnglish
Article number414
JournalInternational Journal of Environmental Research and Public Health
Volume15
Issue number3
DOIs
StatePublished - Mar 2018
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2018 by the authors. Licensee MDPI, Basel, Switzerland.

Keywords

  • Drug delivery
  • Nanocomposite
  • Ondansetron
  • Sodium dodecyl sulphate

ASJC Scopus subject areas

  • Pollution
  • Public Health, Environmental and Occupational Health
  • Health, Toxicology and Mutagenesis

Fingerprint

Dive into the research topics of 'Sodium dodecyl sulphate-supported nanocomposite as drug carrier system for controlled delivery of ondansetron'. Together they form a unique fingerprint.

Cite this